Molnupiravir and nirmatrelvir–ritonavir reduce mortality risk during post-acute COVID-19 phase

Eric Yuk Fai Wan; Boyuan Wang; Sukriti Mathur; Cheyenne I.Ying Chan; Vincent Ka Chun Yan; Francisco Tsz Tsun Lai; Celine Sze Ling Chui; Xue Li; Carlos King Ho Wong; Philip Hei Li; Chak Sing Lau; Ian Chi Kei Wong; Esther Wai Yin Chan

doi:10.1016/j.jinf.2023.02.029

Molnupiravir and nirmatrelvir–ritonavir reduce mortality risk during post-acute COVID-19 phase

Eric Yuk Fai Wan
, Boyuan Wang
, Sukriti Mathur
, Cheyenne I.Ying Chan
, Vincent Ka Chun Yan
, Francisco Tsz Tsun Lai
, Celine Sze Ling Chui
, Xue Li
, Carlos King Ho Wong
, Philip Hei Li
, Chak Sing Lau
, Ian Chi Kei Wong
, Esther Wai Yin Chan^*

^*Corresponding author for this work

Aston University

University of Hong Kong
Laboratory of Data Discovery for Health
The University of Hong Kong–Shenzhen Hospital
The University of Hong Kong, Shenzhen Institute of Research and Innovation

Research output: Contribution to journal › Letter, comment/opinion or interview › peer-review

10 Citations (SciVal)

Original language	English
Pages (from-to)	622-625
Number of pages	4
Journal	Journal of Infection
Volume	86
Issue number	6
DOIs	https://doi.org/10.1016/j.jinf.2023.02.029
Publication status	Published - Jun 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.jinf.2023.02.029Licence: CC BY 4.0

Cite this

@article{caac3eb56b014e829caf9d7bf7f7a154,

title = "Molnupiravir and nirmatrelvir–ritonavir reduce mortality risk during post-acute COVID-19 phase",

author = "Wan, \{Eric Yuk Fai\} and Boyuan Wang and Sukriti Mathur and Chan, \{Cheyenne I.Ying\} and Yan, \{Vincent Ka Chun\} and Lai, \{Francisco Tsz Tsun\} and Chui, \{Celine Sze Ling\} and Xue Li and Wong, \{Carlos King Ho\} and Li, \{Philip Hei\} and Lau, \{Chak Sing\} and Wong, \{Ian Chi Kei\} and Chan, \{Esther Wai Yin\}",

year = "2023",

month = jun,

doi = "10.1016/j.jinf.2023.02.029",

language = "English",

volume = "86",

pages = "622--625",

journal = "Journal of Infection",

issn = "0163-4453",

publisher = "W.B. Saunders Ltd",

number = "6",

}

TY - JOUR

T1 - Molnupiravir and nirmatrelvir–ritonavir reduce mortality risk during post-acute COVID-19 phase

AU - Wan, Eric Yuk Fai

AU - Wang, Boyuan

AU - Mathur, Sukriti

AU - Chan, Cheyenne I.Ying

AU - Yan, Vincent Ka Chun

AU - Lai, Francisco Tsz Tsun

AU - Chui, Celine Sze Ling

AU - Li, Xue

AU - Wong, Carlos King Ho

AU - Li, Philip Hei

AU - Lau, Chak Sing

AU - Wong, Ian Chi Kei

AU - Chan, Esther Wai Yin

PY - 2023/6

Y1 - 2023/6

UR - https://www.scopus.com/pages/publications/85156242015

UR - https://www.sciencedirect.com/science/article/pii/S0163445323001172?via%3Dihub

U2 - 10.1016/j.jinf.2023.02.029

DO - 10.1016/j.jinf.2023.02.029

M3 - Letter, comment/opinion or interview

C2 - 36822409

AN - SCOPUS:85156242015

SN - 0163-4453

VL - 86

SP - 622

EP - 625

JO - Journal of Infection

JF - Journal of Infection

IS - 6

ER -

Molnupiravir and nirmatrelvir–ritonavir reduce mortality risk during post-acute COVID-19 phase

UN SDGs

Access to Document

Other files and links

Cite this